Corcept Therapeutics CORT
NASDAQ CORT
$115.16 +0.42 (+0.37%)
As of: Sep 30, 2026 · 10:25 AM EDT

Corcept Therapeutics (CORT) Total Non-Current Liabilities (2017 - 2026)

Updated

Corcept Therapeutics (CORT) posted Total Non-Current Liabilities of $167.44 million for Q2 2026, up 11.4% from $150.25 million a year earlier and up 3.6% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Corcept Therapeutics' Total Non-Current Liabilities came in at $173.67 million, up 18.2% from FY2024.

  • Annual Total Non-Current Liabilities has increased for four consecutive years, with a five-year compound annual growth rate of 29.3% (FY2020 to FY2025).
  • In prior years, Corcept Therapeutics' Total Non-Current Liabilities was $146.88 million in FY2024 (+40.5%), $104.51 million in FY2023 (+44.2%), $72.49 million in FY2022 (+52.5%) and $47.54 million in FY2021 (-0.9%).
  • Quarterly Total Non-Current Liabilities has run from a low of $44.76 million in Q3 2021 to a high of $177.57 million in Q3 2025 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last 18 quarters, with growth averaging 27.0% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q3 2023, with growth of 129.7%; the weakest was Q4 2021, with a decline of 0.9%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $161.56 million (Q1 2026), $173.67 million (Q4 2025) and $177.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Corcept Therapeutics 12.50 Bn 11.06 Bn 252.09 Mn 167.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 167.44 Mn
Mar 31, 2026 161.56 Mn
Dec 31, 2025 173.67 Mn
Sep 30, 2025 177.57 Mn
Jun 30, 2025 150.25 Mn
Mar 31, 2025 148.92 Mn
Dec 31, 2024 146.88 Mn
Sep 30, 2024 132.58 Mn
Jun 30, 2024 106.38 Mn
Mar 31, 2024 97.20 Mn
Dec 31, 2023 104.51 Mn
Sep 30, 2023 121.87 Mn
Jun 30, 2023 93.06 Mn
Mar 31, 2023 78.87 Mn
Dec 31, 2022 72.49 Mn
Sep 30, 2022 53.07 Mn
Jun 30, 2022 49.06 Mn
Mar 31, 2022 57.80 Mn
Dec 31, 2021 47.54 Mn
Sep 30, 2021 44.76 Mn
API Access

Corcept Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CORT&period=max&api_key=YOUR_API_KEY